mRNA Sequencing Market Forecast, Trend Analysis & Competition Tracking - Global Review 2021 to 2031

mRNA Sequencing Market Forecast and CAGR

According to the latest research by Fact.MR, the mRNA Sequencing market is set to witness steady growth during 2021-2031. The market has been a highly fragmented market developing at a gradual rate and is expected to witness lucrative growth with the increasing utilization of methodologies by major participants; the market is anticipated to increase over the projected skyline.

What is Driving Demand for mRNA Sequencing?

Factors like development in genome mapping programs are projected to drive market development. In addition, technological advancements to support the demand. The technological advancements have enabled analysts to gather important information about epidemiology and public health studies, sequence bacteria and viruses and help identify causes that may add to the virulence.

The possibilities of successful therapy increase when infectious diseases and cancer are detected at the beginning stage. One of the main reasons that boost the development of the mRNA sequencing market is the increasing occurrences of cancer and other infections.

Increasing demand for DNA testing likely to boost mRNA Sequencing Sales

The demand for mRNA sequencing is to be driven by increasing demand for DNA testing. Interest in DNA testing is rising, because of developments in entire exome and genome sequencing methods, cost-effectiveness and faster results of the process when contrasted with genotyping based DNA microarray.

The mRNA sequencer recognizes DNA by estimating the progressions in the electrical conductivity created by DNA strands passing through the biological pore. This innovation empowered the estimation of episodes like the Zika virus. Moreover, GenapSys, a U.S. - based designer of mRNA sequencing advancements for applied genomic testing, presented a GENIUS sequencer, which can sequence DNA anywhere.

U.S and Canada mRNA Sequencing Market Outlook

In North America, the U.S. dominates the mRNA sequencing market. This can fundamentally be credited to the government support through funds for genomics research, growing prevalence of target diseases, advancements in RNA-Seq products, rising research on inherited rare diseases and cancer, and therefore the solid presence of key players like Thermo Fisher (US), Illumina (US), and Agilent Technologies (US).

Europe Demand Outlook for mRNA Sequencing

Europe is expected to be the second most lucrative region for the market owing to several factors. Some key factors leading to the growth are cost-effective and rapid sequencing, increasing hereditary disease prevalence, use of genomics in drug development and discovery, increasing mRNA sequencing choice overall as well as increasing cancer cases globally. Collaborations and several research activities also expected to boost the market.

Germany is projected to hold the highest market share owing to the increasing transfusion procedures such as heart surgery, chemotherapy, organ transplants, etc. The low cost of screening various infectious diseases is also one of the driving factors. As per the World Health Organization, around 2 million individuals in Germany donate blood regularly.

Who are the Key Manufacturers and Suppliers of mRNA Sequencing?

Some of the leading manufacturers and suppliers of mRNA Sequencing include

• Toray Industries, Inc.
• SGL Group
• Mitsubishi Chemical Holdings
• Formosa Plastics Corporation
• Hexcel Corporation
• Kureha Corporation
• Evonik Industries
• Hexcel Corporation
• Teijin Limited
• Royal DSM
• SABIC
• Solvay.

The mRNA Sequencing market is highly fragmented, with the existence of many large-scale players available in global markets, and various small-scale participants in regional markets. Major players are associated with adopting strategies like acquisitions and mergers, launching new products, and partnerships to consolidate their position in the market. Also, major players are funding largely in the research and development to produce advanced products. Worldwide, they are involved in long term contracts with medical care organizations and are involving in partnerships and strategic alliances with other players in various nations to extend their business.

mRNA Sequencing Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company

Key Segments

By Product & Service

• Sample Preparation
• Application
• Method
• Sequencing Platforms & Consumables for RNA Sequencing
• RNA Sequencing Services
• Data Analysis, Storage, and Management

By Technology

• Sequencing by Synthesis (SBS)
• Ion Semiconductor Sequencing
• Single-molecule Real-time (SMRT) Sequencing
• Nanopore Sequencing

By Application

• De Novo Transcriptome Assembly
• Expression Profiling Analysis
• Variant Calling & Transcriptome Epigenetics
• Small RNA Sequencing

By End User

• Research Centers and Academic & Government Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

By Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.